Global Uterine Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Uterine Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Global Uterine Cancer Diagnostics Market, By Diagnostic Type (Instrument Based and Procedure Based), Type (Endometrial Cancer and Uterine Sarcoma), Age Group (<30, 31-40, 41-50, 51-60 And >60), End User (Hospitals, Diagnostic Centres, Cancer Research Centre, Ambulatory Surgical Centres, Specialized Clinics, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Rest of Europe, Japan, China, South Korea, India, Australia, New Zealand, Hong Kong, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, Rest of Asia-Pacific, South Africa, UAE., Saudi Arabia, Kuwait, Rest of the Middle East and Africa, Brazil, Argentina, Venezuela and Rest of South America) Industry Trends and Forecast to 2030

Market Definition

Diagnosis of uterine cancer includes ultrasound, biopsy procedures, and blood tests. Ultrasound tests use sound waves and produce images of the ovaries and uterus. Two types of ultrasound are included in diagnostic testing for uterine cancer: abdominal ultrasound and transvaginal ultrasound. An abdominal scan test involves scanning the full bladder with a small probe across the abdomen, while a transvaginal scan involves inserting a probe tube into the vagina to scan or create an image. Biopsy procedures include endometrial biopsy, hysteroscopy, and dilation and curettage.

Cancer is one of the leading causes of death worldwide, and the prevalence of this disease has increased at an alarming rate. Therefore, health professionals are focusing on developing effective screening and treatment solutions to control obesity rates. Moreover, an endometrial biopsy involves removing some malignant tissue from the endometrium and sending it for a testing procedure. The growing number of geriatric women in the U.S. is also a major factor contributing to the growth of the uterine cancer diagnostic market.

Market Segmentation

The global uterine cancer diagnostic market is segmented into eight notable segments which are based on diagnostic type, type, age group, end user, and distribution channel.
• On the basis of diagnostic type, the global uterine cancer diagnostic market is segmented into instrument based and procedure based
• On the basis of type, the global uterine cancer diagnostic market is segmented into endometrial cancer and uterine sarcoma
• On the basis of age group, the global uterine cancer diagnostic market is segmented into <30, 31-40, 41-50, 51-60, and >60
• On the basis of end user, the global uterine cancer diagnostic market is segmented into hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, specialized clinics, and others
• On the basis of distribution channel, the global uterine cancer diagnostic market is segmented into direct tender, third party distributors, and others

Market Players

Some of the major players operating in the global uterine cancer diagnostic market are:
• F-Hoffmann La Roche Ltd.
• Siemens Healthcare Private Limited
• Narang Medical Limited
• ESAOTE SPA
• Olympus Corporation
• Arquer Diagnostics Ltd
• Guzip Biomarkers Corporation
• General Electric Company
• Canon Medical Systems ANZ Pty Limited
• KARL STORZ SE & Co. KG
• Medtronic
• Stryker
• Surtex Instruments Limited
• Koninklijke Philips N.V.
• FUJIFILM Corporation
• AED.MD
• Jalal Surgical
• Integra LifeSciences
• B. Braun Melsungen AG
• GRAIL